C07D 241/04
Having no double bonds between ring members or between ring members and
Official title: having no double bonds between ring members or between ring members and non-ring members
C07D241/04 (Having no double bonds between ring members or between ring members and) appears on 859 US grants and 1,002 published applications in this corpus.
Search patents in C07D- Granted patents
- 859
- Published applications
- 1,002
- Assignees
- 576
- Inventors
- 3,077
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 3 | 0 |
| 1978 | 3 | 0 |
| 1979 | 2 | 0 |
| 1980 | 5 | 0 |
| 1981 | 4 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 3 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 4 | 0 |
| 1989 | 3 | 0 |
| 1990 | 8 | 0 |
| 1991 | 5 | 0 |
| 1992 | 4 | 0 |
| 1993 | 5 | 0 |
| 1994 | 5 | 0 |
| 1995 | 7 | 0 |
| 1996 | 5 | 0 |
| 1997 | 18 | 0 |
| 1998 | 21 | 0 |
| 1999 | 21 | 0 |
| 2000 | 13 | 0 |
| 2001 | 15 | 3 |
| 2002 | 13 | 13 |
| 2003 | 15 | 30 |
| 2004 | 9 | 34 |
| 2005 | 18 | 26 |
| 2006 | 11 | 25 |
| 2007 | 21 | 32 |
| 2008 | 11 | 30 |
| 2009 | 23 | 34 |
| 2010 | 27 | 43 |
| 2011 | 21 | 40 |
| 2012 | 33 | 29 |
| 2013 | 31 | 41 |
| 2014 | 34 | 48 |
| 2015 | 46 | 43 |
| 2016 | 32 | 43 |
| 2017 | 34 | 48 |
| 2018 | 40 | 35 |
| 2019 | 39 | 64 |
| 2020 | 41 | 80 |
| 2021 | 46 | 59 |
| 2022 | 51 | 47 |
| 2023 | 31 | 53 |
| 2024 | 26 | 33 |
| 2025 | 22 | 39 |
| 2026 | 21 | 30 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Salt containing piperazine polycyclic derivative, crystal form thereof, preparation method therefor, and use thereof6 Oct 2026US 12,753,166 B2Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Inhibitors and uses thereof22 Sep 2026US 12,740,991 B2Vividion Therapeutics, Inc.
- Inhibitors of spinster homolog 2 (SPNS2) for use in therapy22 Sep 2026US 12,741,944 B2University of Virginia Patent Foundation
- Amyloid targeting agents and methods of using the same22 Sep 2026US 12,741,949 B2Amydis, Inc.
- Inhibitors of JUN N-Terminal Kinases (JNK1, JNK2, and/or JNK3) and Mitogen-Activated Protein Kinases (MAPK8, MAPK9, and/or MAPK10) and Methods of Using Same1 Oct 2026US 2026/0294922 A1
- Bulky and small-steric-hindrance ligand and use thereof17 Sep 2026US 2026/0273518 A1Dg Hc Optical Co., Ltd
- Use of hydroxy substituted urones as cure accelerators3 Sep 2026US 2026/0258191 A1Hexcel Composites Limited
- Substituted phenol derivative and use thereof30 Jul 2026US 2026/0217651 A1Chengdu MFS Pharma. Co., Ltd.
- Amyloid targeting agents30 Jul 2026US 2026/0217667 A1Amydis, Inc.
Most cited
By later US patents
- Photodecomposable bases and photoresist compositions470US 8,614,047 B2International Business Machines Corporation · 2013
- Lipids and compositions for intracellular delivery of biologically active compounds247US 8,691,750 B2Axolabs GmbH · 2014
- Arylsulfonyl hydroxamic acid derivatives as MMP and TNF inhibitors218US 5,861,510 APfizer Inc. · 1999
- Nitrogen containing heteroaromatics as factor Xa inhibitors211US 6,020,357 ADuPont Pharmaceuticals Company · 2000
- HIV protease inhibitors useful for the treatment of AIDS118US 5,413,999 AMerck & Co., Inc. · 1995